{
    "title": "115_hr2871",
    "content": "The Act may be cited as the \"Preserving Patient Access to Compounded Medications Act of 2017\" and allows for office-use compounding when authorized by state law. The \"Preserving Patient Access to Compounded Medications Act of 2017\" allows for office-use compounding when authorized by state law. Section 503A(a) of the Federal Food, Drug, and Cosmetic Act is amended to include compounding by licensed pharmacists or physicians for administration to patients in office or clinical settings. The \"Preserving Patient Access to Compounded Medications Act of 2017\" allows for office-use compounding when authorized by state law. Section 503A(a) of the Federal Food, Drug, and Cosmetic Act is amended to include compounding by licensed pharmacists or physicians for administration to patients in office or clinical settings. Additionally, the Act requires compliance with the United States Pharmacopeia or National Formulary monograph. Section 503A(b)(1)(A) of the Federal Food, Drug, and Cosmetic Act is amended to include compliance with monograph standards in the United States Pharmacopeia or National Formulary for drug substances or dietary supplements. The text chunk states that a drug substance or dietary supplement must not be a component of an approved drug but must appear on a list developed by the Secretary. SEC. 4. DEFINITIONS. In subsection (e) of section 503A of the Federal Food, Drug, and Cosmetic Act, definitions for compounding, distribute/distribution, and dispense are clarified. Compounding excludes acts done according to approved labeling, distribute/distribution excludes dispensing of compounded drugs, and dispense refers to the delivery of compounded drug products to patients. Compounded drugs are prepared for delivery to patients, their agents, or healthcare facilities based on valid prescriptions. SEC. 5. APPLICABILITY OF RECORDS EXEMPTION FOR COMPOUNDING PHARMACIES. Section 704(a)(2)(A) of the Federal Food, Drug, and Cosmetic Act is amended for pharmacies maintaining establishments in compliance with local pharmacy and medicine laws, regularly dispensing prescription drugs upon practitioner orders, and not manufacturing drugs or devices. Pharmacies exempt from registration under the Federal Food, Drug, and Cosmetic Act are those that comply with local pharmacy and medicine laws, regularly dispense prescription drugs upon practitioner orders, and do not manufacture drugs or devices. Pharmacies exempt from registration under the Federal Food, Drug, and Cosmetic Act are those that comply with local pharmacy and medicine laws, regularly dispense prescription drugs upon practitioner orders, and do not prepare, compound, or process drugs or devices for sale other than in the regular course of their business. The Secretary of Health and Human Services must issue rules within 90 days of this Act's enactment to implement the amendments. Additionally, rules must be promulgated to carry out provisions of section 503A of the Federal Food, Drug, and Cosmetic Act not affected by this Act."
}